摘要
目的:探讨抗感染药师开展临床药学监护的模式。方法:对2015年111例抗感染药学会诊资料进行整理和分析,总结临床药师参与药物治疗过程的关键因素。结果:111例会诊病例中肺部感染占29.7%,有病原学检验依据的占55.8%,有肿瘤病史患者占52.3%。药师持续监护平均周期是7.0 d,药师会诊意见采纳率为90.1%,感染好转病例占85.6%。结论:通过药学会诊持续开展患者药学监护使药师参与治疗程度提高,更容易取得临床医疗团队的信任。
Objective： To discuss the pattern of pharmaceutical care by clinical pharmacists major in anti- infection. Methods： By systemizing and analyzing the 111 cases record of pharmacy consultation in infectious patients in 2015,summarized the key factors for clinical pharmacists in the course of therapy among the medical team. Results： In the 111 cases record of pharmacy consultation,29. 7% were pulmonary infection,55. 8% were on the basis of pathogen,52. 3%had medical history of tumor. The average period of persist care for patients was 7. 0 days and the adoption rate of advice by clinical pharmacists was 90. 1%,the percent of recovered patients was 85. 6%. Conclusion： With the continue pharmaceutical care through consultation by clinical pharmacists,confidence had been developed between clinical pharmacists and other members of medical team.
出处
《药物流行病学杂志》
CAS
2016年第7期459-462,共4页
Chinese Journal of Pharmacoepidemiology
关键词
抗感染
药学会诊
药学监护
Anti-infection
Pharmacy consultation
Pharmaceutical care
